🇫🇷 Eurobio Scientific SA
ALERS.PAFundamentals
Gross Margin
40.5%
Op. Margin
9.1%
Net Margin
2.9%
ROIC
5.6%
Rev Growth
9.1%
Valuation
Price
19.65 EUR
Day
+0.26%
52-Week Range
19.30 - 25.70
Market Cap
198M EUR
Fwd P/E
17.4x
EV/EBITDA
8.6x
Div Yield
-
Annual income statement #
Eurobio Scientific SA annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 169.0m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 169.0m | 15.5m | 4.9m | 2.9% |
| 2024 | 154.9m | 13.4m | 4.0m | 2.6% |
| 2023 | 130.6m | 10.1m | 4.8m | 3.7% |
| 2022 | 152.6m | 30.9m | 24.9m | 16.3% |
| 2021 | 184.7m | 72.0m | 60.5m | 32.8% |
| 2020 | 188.9m | 81.2m | 73.5m | 38.9% |
| 2019 | 59.5m | 569,000 | 3.2m | 5.3% |
| 2018 | 51.1m | -1.2m | -2.8m | -5.4% |
| 2017 | 42.8m | -5.8m | -10.0m | -23.3% |
| 2016 | 27.8m | -7.4m | -7.7m | -27.8% |
Financial Data #
Segment Breakdown #
Peers #
ICE.WA BICO.ST SBS.DE PAX.ST CEVI.ST CRAD-B.ST EPIS-B.ST SEDANA.ST GBT.PA DVYSR.ST ·
Compare in Screener
Dividends
Bubble
Events #
| Date | Type | Details | Price | Amount |
|---|